High Potency of a Novel Resveratrol Derivative, 3,3′,4,4′-Tetrahydroxy-<i>trans</i>-stilbene, against Ovarian Cancer Is Associated with an Oxidative Stress-Mediated Imbalance between DNA Damage Accumulation and Repair

<div>Effect of RVT and 3,3′,4,4′-THS on the activity of p38 MAPK in ovarian cancer cells. The level of enzyme activity upon cancer cell treatment with stilbenes for 24 h was estimated according to the ratio of phosphorylated to total p38 MAPK. The asterisks indicate a significant difference as compared to the control group. The hashes indicate a significant difference as compared to cells subjected to RVT. The experiments were performed in hexaplicate.</div>

Oxidative Medicine and Cellular Longevity

fig7

Figure 7

Figure 7: High Potency of a Novel Resveratrol Derivative, 3,3′,4,4′-Tetrahydroxy-<i>trans</i>-stilbene, against Ovarian Cancer Is Associated with an Oxidative Stress-Mediated Imbalance between DNA Damage Accumulation and Repair 

Figure 7 | High Potency of a Novel Resveratrol Derivative, 3,3′,4,4′-Tetrahydroxy-trans-stilbene, against Ovarian Cancer Is Associated with an Oxidative Stress-Mediated Imbalance between DNA Damage Accumulation and Repair 